Venture capital firm

LYZZ Capital

A global healthcare-focused venture capital and private equity firm investing across the United States and China

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

LYZZ Capital is a healthcare-focused venture capital and private equity firm, investing through funds denominated in both US and Chinese currencies. Its team is made up of investment and operating professionals with backgrounds at pharmaceutical and biotechnology companies as well as Wall Street firms, combining scientific, medical and financial expertise, and has worked together for more than a decade in what it describes as a cordial, team-oriented environment. The team's biotechnology investing experience extends back more than 20 years, including over 15 years working in China. The firm says it invests in talent, assets and technologies on a global basis, with particular emphasis on unmet medical needs and substantial market opportunities specifically within China.

Summary written by TrustList from the business's own published information, Sep 2026.

Gallery

2 images - click to enlarge

Categories & features

Rankings

LYZZ Capital is ranked on 2 TrustList rankings: #28 on 1 and #49 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. LYZZ Capital has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 2 rankings

#28of 45
Shanghai
It is one of 4 here listing biotech.
Of the 45 here, 6 also cover healthtech and 5 also cover banking; 25 also work in Hong Kong and 14 also work in New York City.
Behind Lilly Asia Ventures, ahead of Micron Ventures.
#49of 79
Biotech investors
Of the top 65 here, 17 also cover science and 12 also cover partners; 14 also work in Boston and 13 also work in San Francisco.
Behind Longfellow Venture Partners, ahead of Mass Medical Angels.